Ban on thimerosal in draft treaty on mercury: Why the AAP'S position in 2012 is so important

Pediatrics

Volumn 131, Issue 1, 2013, Pages 152-153

  Cooper, Louis Z ^a   Katz, Samuel L ^b  

^a Columbia University ^*  (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCURY; METHYLMERCURY; THIOMERSAL; VACCINE;

DRUG LEGISLATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH HAZARD; HUMAN; IMMUNIZATION; MEDICAL SOCIETY; NOTE; PANDEMIC INFLUENZA; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; TOXICOLOGY; UNITED STATES; WORLD HEALTH ORGANIZATION;

ACADEMIES AND INSTITUTES; HUMANS; INTERNATIONAL COOPERATION; MERCURY; PEDIATRICS; THIMEROSAL; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 84872831539     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-1823     Document Type: Note

References (4)

1. Ban on mercury-based products would risk global immunization efforts, says AAP, WHO. Available at: Http://aapnewspublications.org/content/33/7/4. Accessed June 1, 2012
2. Centers for Disease Control and Prevention (CDC). Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep. 1999;48(26):563-565
3. Orenstein WA, Paulson JA, Brady MT, Cooper LZ, Seib K. Global vaccination recommendations and thimerosal. Pediatrics. 2012;131(1):149-151
4. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics. 2001;107(5):1147-1154